Fibromyalgia Assessment Screening Tool: Clues to Fibromyalgia on a Multidimensional Health Assessment Questionnaire for Routine Care

Objective. To develop feasible indices as clues to comorbid fibromyalgia (FM) in routine care of patients with various rheumatic diseases based only on self-report multidimensional Health Assessment Questionnaire (MDHAQ) scores, which are informative in all rheumatic diagnoses studied. Methods. All patients with all diagnoses complete an MDHAQ at each visit; the 2011 FM criteria questionnaire was added to the standard MDHAQ between February 2013 and August 2016. The proportion of patients who met 2011 FM criteria or had a clinical diagnosis of FM was calculated. Individual candidate MDHAQ measures were compared to 2011 FM criteria using receiver-operating characteristic (ROC) curves; cutpoints to recognize FM were selected from the area under the curve (AUC) for optimal tradeoff between sensitivity and specificity. Cumulative indices of 3 or 4 MDHAQ measures were analyzed as fibromyalgia assessment screening tools (FAST). Results. In 148 patients, the highest AUC in ROC analyses versus 2011 FM criteria were seen for MDHAQ symptom checklist, self-report painful joint count, pain visual analog scale (VAS), and fatigue VAS. The optimal cutpoints were ≥ 16/60 for symptom checklist, ≥ 16/48 for self-report painful joint count, and ≥ 6/10 for both pain and fatigue VAS. Cumulative FAST indices of 2/3 or 3/4 MDHAQ measures correctly classified 89.4–91.7% of patients who met 2011 FM criteria. Conclusion. FAST3 and FAST4 cumulative indices from only MDHAQ scores correctly identify most patients who meet 2011 FM criteria. FAST indices can assist clinicians in routine care as clues to FM with a general rheumatology rather than FM-specific questionnaire.

[1]  F. Wolfe,et al.  The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.

[2]  T. Pincus,et al.  A clue from a self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. The P-VAS:D-ADL ratio. , 1990, Arthritis and rheumatism.

[3]  A. Gibofsky.  American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.

[4]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[5]  J. Block,et al.  Fibromyalgia Assessment Screening Tools (FAST) Based on Only Multidimensional Health Assessment Questionnaire (MDHAQ) Scores as Clues to Fibromyalgia , 2019, ACR open rheumatology.

[6]  T. Pincus,et al.  Further clues to recognition of patients with fibromyalgia from a simple 2-page patient multidimensional health assessment questionnaire (MDHAQ). , 2004, Clinical and experimental rheumatology.

[7]  T. Pincus,et al.  Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research. , 2007, Clinical and experimental rheumatology.

[8]  F. Wolfe,et al.  Fibromyalgia Prevalence, Somatic Symptom Reporting, and the Dimensionality of Polysymptomatic Distress: Results From a Survey of the General Population , 2013, Arthritis care & research.

[9]  F. Wolfe,et al.  Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia , 2011, The Journal of Rheumatology.

[10]  T. Pincus,et al.  Quantitative Data for Care of Patients with Systemic Lupus Erythematosus in Usual Clinical Settings: A Patient Multidimensional Health Assessment Questionnaire and Physician Estimate of Noninflammatory Symptoms , 2011, The Journal of Rheumatology.

[11]  R M Bennett,et al.  The fibromyalgia impact questionnaire: development and validation. , 1991, The Journal of rheumatology.

[12]  F. Wolfe,et al.  Primary and Secondary Fibromyalgia Are The Same: The Universality of Polysymptomatic Distress , 2018, The Journal of Rheumatology.

[13]  J. Baker,et al.  Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3 , 2016, Clinical Rheumatology.

[14]  F. Wolfe,et al.  Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. , 1999, Arthritis and rheumatism.

[15]  F. Wolfe,et al.  Diagnosis of Fibromyalgia: Disagreement Between Fibromyalgia Criteria and Clinician‐Based Fibromyalgia Diagnosis in a University Clinic , 2019, Arthritis care & research.

[16]  F. Wolfe,et al.  Fibrositis (Fibromyalgia) in rheumatoid arthritis. , 1984, The Journal of rheumatology.

[17]  T. Pincus,et al.  Patient self‐report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis , 2013, Arthritis care & research.

[18]  L. Queiroz.  Worldwide Epidemiology of Fibromyalgia , 2013, Current Pain and Headache Reports.

[19]  M. Liang,et al.  A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. , 1995, Arthritis and rheumatism.

[20]  S. Koca,et al.  A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis , 2015, Rheumatology International.

[21]  A. Dinno,et al.  Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis , 2014, Clinical Rheumatology.

[22]  Philip J Mease,et al.  2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.

[23]  T. Pincus,et al.  The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care. , 2009, Rheumatic diseases clinics of North America.

[24]  T. Pincus,et al.  Flowsheets that include MDHAQ physical function, pain, global, and RAPID3 scores, laboratory tests, and medications to monitor patients with all rheumatic diseases: an electronic database for an electronic medical record. , 2009, Rheumatic diseases clinics of North America.

[25]  T. Pincus,et al.  MDHAQ/RAPID3 to Recognize Improvement Over 2 Months in Usual Care of Patients With Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy, and Gout, as Well as Rheumatoid Arthritis , 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[26]  A. Marchesoni,et al.  Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients , 2012, Archives of Dermatological Research.

[27]  P. Thune.  The prevalence of fibromyalgia among patients with psoriasis. , 2005, Acta dermato-venereologica.

[28]  T. Pincus.  Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? , 2009, Bulletin of the NYU hospital for joint diseases.

[29]  T. Pincus,et al.  Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. , 2005, The Journal of rheumatology.

[30]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.